EP2985031

USE OF CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF VARIOUS DISEASES

  • :
    EP einkaleyfi: Þýðing ekki lögð inn
  • :
    2.6.2009
  • :
    12.4.2017
  • :
    15000994.2
  • :
    1.6.2029
  • :
    USE OF CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF VARIOUS DISEASES

2.6.2009
12.4.2017
  • :
    Xigen Inflammation Ltd.
  • :
    Arch. Makariou III 195 Neocleous House, 3030, Limassol, CY
  • :
    Bonny, Christophe
  • :
    Avenches, CH
  • :
    PCT/EP2008/004341
  • :
    30.5.2008
  • :
    WO
  • :
    A61K 38/01, A61K 38/03, A61K 38/04, A61P 9/00, A61P 11/00, A61P 17/00, A61P 25/00, A61P 31/12, A61P 37/00